Scale weight typically rises 1-3 lbs in this window
Centers for Disease Control and Prevention (CDC) data show that over 100 million US adults are obese, PwC noted, while an analysis published in JAMA Cardiology in November determined that 137 million Americans may be eligible for the GLP-1 drug semaglutide (prescribed as Wegovy for weight loss and Ozempic for type 2 diabetes)
While these mechanisms provide significant metabolic benefits for diabetes management and weight loss, they may also contribute to various side effects, including headaches
The reason for this postulation is based on the expression of melanotransferrin (melanoma-specific peptide that may play role in iron metabolism)
Signs You Are Experiencing Facial Drooping Increased signs of aging, such as more lines and wrinkles Loss of facial fat, which can lead the skin to become loose and sag A hollowed-out or gaunt appearance to the face Drooping skin around the cheeks, jawline, and under the eyes Development of dark circles or hollows under the eyes Exaggerated nasolabial folds (lines from nose to mouth) Increased visibility of cheekbones and other facial bones due to diminished fat Overall loss of facial fullness, plumpness, and youthful contours Ways To Restore Facial Volume There are a few surgical and non-surgical options for reducing facial sagging from Ozempic
For example, a 2025 study in the Journal of the American Medical Association (JAMA) found people taking Ozempic were about 1.8 times as likely to experience vision loss from NAION, than those prescribed other diabetes medications